Gabriela Araújo Attie

Gabriela Araújo Attie

Auto-generated profile, based on publicly available information

Gabriela Araújo Attie

Universidade Federal de São Paulo São PauloSP Brazil Universidade Federal de São Paulo, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2019 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
PDF file
GAGabriela Araújo Attie
Gabriela Araújo Attie
CFCarolina Dutra Queiroz Flumignan
Carolina Dutra Queiroz Flumignan
MSMelissa Andreia de Moraes Silva
Melissa Andreia de Moraes Silva
EBEdivando de Moura Barros
Edivando de Moura Barros
RDRaul Muffato Daolio
Raul Muffato Daolio
RFRonald Luiz Gomes Flumignan
Ronald Luiz Gomes Flumignan
KEY WORDS: Ultrasonography; Punctures; Review; Evidence-based medicine; Vascular access devices

2 October 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
CMCarina Mucciolo Melo
Carina Mucciolo Melo
HPHenrique Pereira Prado
Henrique Pereira Prado
GAGabriela Araújo Attie
Gabriela Araújo Attie
DRDaniel Lacaz Ruiz
Daniel Lacaz Ruiz
MGManoel João Batista Castello Girão
Manoel João Batista Castello Girão
MPMaria Aparecida Silva Pinhal
Maria Aparecida Silva Pinhal
To investigate the possible genes that may be related to the mechanisms that modulate heparanase-1. The analysis was conducted at Universidade Federal de São Paulo, on the data provided by: The Cancer Genome Atlas, University of California Santa Cruz Genome Browser, Kyoto Encyclopedia of Genes and Genomes Pathway Database, Database for Annotation, Visualization and Integrated Discovery Bioinformatics Database and the softwares cBioPortal and Ingenuity Pathway Analysis. Using messenger RNA expression pattern of different molecular subtypes of breast cancer, we proposed that heparinase-1 was co-related with its progression. In addition, genes that were analyzed presented co-expression with heparanase-1. The results that showed that heparanase-1 co-expressed with phosphoinositide 3-kinase adapter protein 1, sialic acid-binding immunoglobulin-like lectin 7, and leukocyte-associated immunoglobulin-like receptor 1 are directed related with immune system evasion during breast cancer progression. Furthermore, cathepsin L was co-expressed with heparanase-1 and transformed inactive heparanase-1 form into active heparanase-1, triggering extracellular matrix remodeling, which contributes to enhanced tumor-host interaction of the tumor. The signaling pathway analysis using bioinformatics tools gives supporting evidence of possible mechanisms related to breast cancer development. Evasion genes of the immune system co-expressed with heparanase-1, a enzyme related with tumor progression.